Fed. Circ. Nixes $29M HemCon Hit In Polymer Patent Suit

Law360, New York (September 26, 2011, 7:30 PM EDT) -- The Federal Circuit on Monday overturned a $29 million damages award against HemCon Medical Technologies Inc. for allegedly infringing Marine Polymer Technologies Inc.'s patent for a polymer that accelerates hemostasis, saying the scope of the patent changed during a re-examination proceeding.

In a split decision, the appeals court concluded that HemCon had absolute intervening rights because Marine Polymer changed the scope of the patent during the re-examination, but remanded the issue to a New Hampshire federal court of whether the company also had equitable intervening rights....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.